Format

Send to

Choose Destination
J Public Health (Oxf). 2015 Dec;37(4):691-3. doi: 10.1093/pubmed/fdu101. Epub 2014 Dec 19.

Limited access to drugs for resistant tuberculosis: a call to action.

Author information

1
Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné BP118, Gabon Division of Internal Medicine, Centre of Tropical Medicine and Travel Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam 1100 DD, The Netherlands Institute of Tropical Medicine, University of Tübingen, Tübingen 72074, Germany Department of Pediatric Pneumology and Immunology, Charité-Universitätsmedizin Berlin, Berlin 10117, Germany.
2
Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné BP118, Gabon Division of Internal Medicine, Centre of Tropical Medicine and Travel Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam 1100 DD, The Netherlands Institute of Tropical Medicine, University of Tübingen, Tübingen 72074, Germany.
3
Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné BP118, Gabon Division of Internal Medicine, Centre of Tropical Medicine and Travel Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam 1100 DD, The Netherlands.
4
Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné BP118, Gabon Institute of Tropical Medicine, University of Tübingen, Tübingen 72074, Germany.
5
Hôpital d'Instruction des Armées OBO, Libreville BP 20404, Gabon.

Abstract

Although the rate of new tuberculosis (TB) cases has been falling worldwide, progress toward the targets for diagnosis and treatment of drug-resistant TB is far off-track. In countries with no reliable TB surveillance system, setbacks and progression of TB control is barely reflected and little is known on the situation in the field. Interviews with health professionals in Gabon revealed limited access to first- and second-line TB drugs and important deficiencies in basic TB control. National and international action needs to be taken to meet the global TB control targets.

KEYWORDS:

Africa; Gabon; accessibility; drug-resistance; tuberculosis treatment

PMID:
25527468
DOI:
10.1093/pubmed/fdu101
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center